![](/img/cover-not-exists.png)
First‐in‐Human Phase I Study of MBC‐11, a Novel Bone‐Targeted Cytarabine‐Etidronate Conjugate in Patients with Cancer‐Induced Bone Disease
Zinnen, Shawn Patrick, Karpeisky, Alexander, Von Hoff, Daniel D., Plekhova, Larisa, Alexandrov, AlexanderLanguage:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2018-0707
Date:
November, 2018
File:
PDF, 672 KB
english, 2018